QC Analyst in Serology 3X (6 months)

TRANSFORMING TRANSFUSION DIAGNOSTICS
QC Analyst in Serology 3X
(6 months)
Department: Quality
Location: Eysins, Switzerland
COMPANY DESCRIPTION
Quotient is a well-established bio-manufacturing organisation, with an internationally
recognised product portfolio and exciting pipeline of new and innovative products. The product
range includes in vitro diagnostics in the field of immunohematology, immunology and
hematology. The company is poised for significant growth in this specialized field of medicine
through the development and commercialisation of the next generation automated platform
for transfusion diagnostics, MosaiQ™. The platform is being designed for use in both patientand-donor testing environments and will combine miniaturization of a full array of existing
Blood Grouping assays on a single consumable with a new instrument. In order to complete
our Quality department, we are looking for a Quality Control Analyst in Serology.
JOB DESCRIPTION
 Perform all the routine Quality Control testing of intermediate and final product
manufactured at Quotient in accordance with operational objectives, statutory and
regulatory requirements and the principles of GMP
 Assist in the organisation of routine work within the department in order to maximise
the use of available resources.
 To ensure that all Quotient’s final products meet the appropriate specifications and
regulatory requirements for release to market.
 Review and update procedures as required to ensure compliance.
 Preparation of reports as required.
QUALIFICATIONS & EXPERIENCE REQUIRED
 Bachelor or equivalent degree in Biochemistry, biology or equivalent.
 1-3 years experience working in QC laboratory (pharmaceutical, medical device or
medical laboratory) and GDP and GMP experience.
 Experience in blood group serology is essential
 Experience in specificity tests for antibodies and red cells phenotyping using
conventional tube methods and CAT system
 Good spoken and written English and French, although French is not essential.
ADDITIONAL INFORMATION
It is expected that in the future this role will operate on a rotating shift pattern.